Literature DB >> 28365028

Sequence-Modified Antibiotic Resistance Genes Provide Sustained Plasmid-Mediated Transgene Expression in Mammals.

Jiamiao Lu1, Feijie Zhang1, Andrew Z Fire2, Mark A Kay3.   

Abstract

Conventional plasmid vectors are incapable of achieving sustained levels of transgene expression in vivo even in quiescent mammalian tissues because the transgene expression cassette is silenced. Transcriptional silencing results from the presence of the bacterial plasmid backbone or virtually any DNA sequence of >1 kb in length placed outside of the expression cassette. Here, we show that transcriptional silencing can be substantially forestalled by increasing the An/Tn sequence composition in the plasmid bacterial backbone. Increasing numbers of An/Tn sequences increased sustained transcription of both backbone sequences and adjacent expression cassettes. In order to recapitulate these expression profiles in compact and portable plasmid DNA backbones, we engineered the standard kanamycin or ampicillin antibiotic resistance genes, optimizing the number of An/Tn sequence without altering the encoded amino acids. The resulting vector backbones yield sustained transgene expression from mouse liver, providing generic DNA vectors capable of sustained transgene expression without additional genes or mammalian regulatory elements.
Copyright © 2017 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  An/Tn tracts; antibiotic resistance gene; non-coding transcription; nucleosomes; plasmid silencing; plasmid vector

Mesh:

Substances:

Year:  2017        PMID: 28365028      PMCID: PMC5417794          DOI: 10.1016/j.ymthe.2017.03.003

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  46 in total

Review 1.  Reducing the immunostimulatory activity of CpG-containing plasmid DNA vectors for non-viral gene therapy.

Authors:  Nelson S Yew; Seng H Cheng
Journal:  Expert Opin Drug Deliv       Date:  2004-11       Impact factor: 6.648

2.  Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo.

Authors:  Zhi-Ying Chen; Cheng-Yi He; Mark A Kay
Journal:  Hum Gene Ther       Date:  2005-01       Impact factor: 5.695

3.  Genome-scale identification of nucleosome positions in S. cerevisiae.

Authors:  Guo-Cheng Yuan; Yuen-Jong Liu; Michael F Dion; Michael D Slack; Lani F Wu; Steven J Altschuler; Oliver J Rando
Journal:  Science       Date:  2005-06-16       Impact factor: 47.728

4.  A new DNA vehicle for nonviral gene delivery: supercoiled minicircle.

Authors:  A M Darquet; B Cameron; P Wils; D Scherman; J Crouzet
Journal:  Gene Ther       Date:  1997-12       Impact factor: 5.250

5.  Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites.

Authors:  P N Cockerill; W T Garrard
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

6.  Molecular biology: RNA discrimination.

Authors:  Monika S Kowalczyk; Douglas R Higgs; Thomas R Gingeras
Journal:  Nature       Date:  2012-02-15       Impact factor: 49.962

7.  Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes.

Authors:  M A Kay; F Graham; F Leland; S L Woo
Journal:  Hepatology       Date:  1995-03       Impact factor: 17.425

8.  Identification of intrinsic termination sites in vitro for RNA polymerase II within eukaryotic gene sequences.

Authors:  D Reines; D Wells; M J Chamberlin; C M Kane
Journal:  J Mol Biol       Date:  1987-07-20       Impact factor: 5.469

9.  Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo.

Authors:  Z Y Chen; C Y He; L Meuse; M A Kay
Journal:  Gene Ther       Date:  2004-05       Impact factor: 5.250

10.  Bidirectional promoters generate pervasive transcription in yeast.

Authors:  Zhenyu Xu; Wu Wei; Julien Gagneur; Fabiana Perocchi; Sandra Clauder-Münster; Jurgi Camblong; Elisa Guffanti; Françoise Stutz; Wolfgang Huber; Lars M Steinmetz
Journal:  Nature       Date:  2009-01-25       Impact factor: 49.962

View more
  4 in total

Review 1.  DNA Vaccines-How Far From Clinical Use?

Authors:  Dominika Hobernik; Matthias Bros
Journal:  Int J Mol Sci       Date:  2018-11-15       Impact factor: 5.923

2.  Reduced Heterochromatin Formation on the pFAR4 Miniplasmid Allows Sustained Transgene Expression in the Mouse Liver.

Authors:  Marie Pastor; Mickäel Quiviger; Julie Pailloux; Daniel Scherman; Corinne Marie
Journal:  Mol Ther Nucleic Acids       Date:  2020-05-20       Impact factor: 8.886

3.  Engineering rules that minimize germline silencing of transgenes in simple extrachromosomal arrays in C. elegans.

Authors:  Mohammed D Aljohani; Sonia El Mouridi; Monika Priyadarshini; Amhed M Vargas-Velazquez; Christian Frøkjær-Jensen
Journal:  Nat Commun       Date:  2020-12-09       Impact factor: 14.919

4.  Production of lentiviral vectors using novel, enzymatically produced, linear DNA.

Authors:  Rajvinder Karda; John R Counsell; Kinga Karbowniczek; Lisa J Caproni; John P Tite; Simon N Waddington
Journal:  Gene Ther       Date:  2019-01-14       Impact factor: 5.250

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.